Profile
Marco Montanari was the founder of OPALIA Pharma SA, which was founded in 1988, where he held the title of General Director.
He also worked as a Portfolio Manager at Lyxor International Asset Management SAS from 2005 to 2007.
Additionally, he worked as the Head of Fixed Income at Deutsche Bank AG (Fund Distributor).
Former positions of Marco Montanari
| Companies | Position | End |
|---|---|---|
Lyxor International Asset Management SAS
 Lyxor International Asset Management SAS Investment ManagersFinance Lyxor International Asset Management SAS (LIAM) is the asset management subsidiary of Lyxor Asset Management SAS, which is ultimately held by SAS Rue la Boétie’s Crédit Agricole SA (EPA: ACA; ADR: CRARY) in France. The firm is headquartered in Puteaux and was founded in 1998. LIAM offers asset allocation, hedge funds, financial planning, and investment advisory services to individual and institutional investors. | Portfolio Manager-Equities | 14/03/2007 |
OPALIA Pharma SA
 OPALIA Pharma SA Pharmaceuticals: MajorHealth Technology OPALIA Pharma manufactures generic drugs and pharmaceuticals. Its products specialize in the fields of dermatology, gastroenterology, rheumatology, and infectiology. The firm also provides consulting service. The company was founded by Marco Montanari and Alya El Hedda in 1988 and is headquartered in Ariana, Tunisia. | Founder | - |
| Deutsche Bank AG (Fund Distributor) | Head-Fixed Income Invts | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Lyxor International Asset Management SAS
Lyxor International Asset Management SAS Investment ManagersFinance Lyxor International Asset Management SAS (LIAM) is the asset management subsidiary of Lyxor Asset Management SAS, which is ultimately held by SAS Rue la Boétie’s Crédit Agricole SA (EPA: ACA; ADR: CRARY) in France. The firm is headquartered in Puteaux and was founded in 1998. LIAM offers asset allocation, hedge funds, financial planning, and investment advisory services to individual and institutional investors. | Finance |
| Deutsche Bank AG (Fund Distributor) | Finance |
OPALIA Pharma SA
OPALIA Pharma SA Pharmaceuticals: MajorHealth Technology OPALIA Pharma manufactures generic drugs and pharmaceuticals. Its products specialize in the fields of dermatology, gastroenterology, rheumatology, and infectiology. The firm also provides consulting service. The company was founded by Marco Montanari and Alya El Hedda in 1988 and is headquartered in Ariana, Tunisia. | Health Technology |
- Stock Market
- Insiders
- Marco Montanari
